ArticleArchives of orthopaedic and trauma surgery2025
Trabecular metal technology (TMT) cups in primary total hip arthroplasty: outcomes and survivorship of a large cohort.
Article in Archives of orthopaedic and trauma surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTotal hip arthroplasty (THA) is a widely performed procedure presenting substantial functional improvement in patients with hip joint pathology. Cementless acetabular components have well renowned popularity for their potential for long-term durability and bone preservation. Among these implants, trabecular metal technology (TMT), particularly using tantalum, has been introduced to enhance biological fixation and implant longevity.
methodsThis retrospective study analyzed 3464 primary THAs performed using tantalum TMT acetabular cups between 2012 and 2022 at a single high-volume arthroplasty center. Patients included were adults undergoing THA for osteoarthritis, hip dysplasia, post-traumatic arthritis, or avascular necrosis, with a minimum follow-up of 24 months. Clinical outcomes were evaluated using the Harris Hip Score (HHS), and implant survivorship was assessed via Kaplan–Meier analysis.
resultsThe mean follow-up was 7.03 years (± 2.58). The mean HHS improved significantly from 46.7 (± 7.2) preoperatively to 91.07 (± 7.8) at final follow-up. The implant survivorship free from any reoperation was 97.78%, while survivorship free from aseptic loosening was 99.89%. Radiographically, mean cup inclination was 41.3° (± 5.9), with signs of potential aseptic loosening in only four cases (0.11%). Complications included 46 infections managed with DAIR/DAPRI and 30 implant-related revisions, primarily due to dislocation or mechanical failure.
conclusionTantalum acetabular components demonstrate excellent mid-term clinical and radiographic performance in a broad patient population, suggesting their utility in both high-demand and compromised bone quality cases. Continued follow-up is necessary to confirm long-term implant survivorship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.